logo-biokuris Biokuris

Targeting unmet medical needs in Chronic Intestinal Diseases


BiOkuris is nominated as a finalist for the Start-Up Award for the 2024 NutraIngredients Awards!

Read more

Our mission

BiOkuris develops next generation medical nutrition products tailored to the unmet medical needs of patients with chronic intestinal diseases.

We believe that patients deserve specific, safe, effective, and science-driven treatments that reduce their daily burden and help them to restore balance.

Our solutions have been specifically designed to improve both the physiopathology and quality of life for the millions of patients living with chronic intestinal diseases.

Discover our innovative platform
Our mission
Our innovative platform

Two patented ingredients with multiple action mechanisms.

Our technology is based on a model that combines chitin-glucan or chitosan.
Our two proprietary active ingredients are derived from nature, vegan, safe, and non-GMO, both manufactured in Belgium. We have already yielded exceptional results via multiple in vitro, in vivo, and human clinical trials that confirmed its beneficial effects.


Biocopolymer of chitine betaglucan with prebiotic properties



Cationic biopolymer with antifungal and film forming capacities

Aspergillus niger Aspergillus niger
  • Derived from nature
  • Non animal
  • Safe
  • Non-GMO
  • Approved by EU-US regulatory authorities

Our unique pipeline

Leveraging proprietary technology
through unique synergistic combinations

biokuris pipeline
biokuris pipeline

We are opening a multitude of potential applications in various diseases in combination or not with other ingredients. This means that our ingredients hold the promise for innovative applications in treating diseases, from chronic conditions affecting the digestive system, such as IBS and IBD, to systemic issues like inflammation and immune system disorders.

The possibility of combining our ingredients with others opens up a new frontier in personalized medicine, where treatments can be tailored to the unique needs and conditions of individual patients.

On the market

Gastrap® Direct

Experience relief from gas and bloating and restore a healthy gut microbiota with our unique solution Gastrap® Direct

Gastrap Direct (BK001) targets and alleviates gas-related symptoms, including bloating, flatulence, and abdominal pain, offering users a sense of comfort and relief.

It aids in the regularization and normalization of intestinal transit, promoting smoother stool evacuation. Additionally, Gastrap Direct contributes to the normalization of intestinal function, supporting overall digestive health.

This product presents a valuable addition to any health and wellness line, providing customers with a solution that addresses common digestive discomforts through its unique properties.

About us

Our company is located near Liege, in Belgium, and we benefit from the rich ecosystem of the “biotech-pharma valley” in Wallonia, allowing us to get access to the best resources to develop our projects. BiOkuris is part of the KitoZyme Group, who for the last 20 years has specialized in the design and manufacturing of biopolymers for Health & Nutrition, Agriculture and Personal Care.


BiOkuris stands at the forefront of gastrointestinal healthcare innovation.

Our nutritional solutions are designed to alleviate the symptoms and improve the lives of those affected by gastrointestinal conditions. Our focus lies in harnessing the power of natural biopolymers, chitin-glucan and chitosan, derived from Aspergillus niger, to create products with innovative synergies that offer real health benefits beyond traditional pharmaceuticals.

As a company, our work encompasses a comprehensive portfolio that extends from pre-clinical developments through to clinical studies, culminating in a commercial product that is establishing its presence in the market.


BiOkuris is led by a team combining expertise in Consumer Health, Pharmaceuticals, Biotechnology and Clinical Medicine.

Read more

François BlondelExecutive Chairman of the Board, Managing Director

Read more

Salvatore ModicaCOO

Read more

Benoit PalmsCBO

Read more

Pr. Pierre DesreumauxPresident of the Scientific Committee CSO

Read more

Dr. Véronique MaquetMember of the Scientific Committee

Read more

Pr. Edouard LouisMember of the Scientific Committee

Read more

Géry LefebvreSRIW

Read more

Benoit FellinNOSHAQ

Read more

Marie HobeCFO